title: Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis.
abstract: OBJECTIVE
  To evaluate the effect of orbital floor triamcinolone acetonide (OFTA) injections on inflammation and visual acuity in active non-infectious uveitis.
  
  
  METHODS
  Monocentre, retrospective study in 94 eyes (86 patients) with acute non-infectious uveitis receiving a single OFTA (40 mg) injection. Outcome measures were anterior chamber (AC) and vitreous cell counts, laser flare photometry, best-corrected visual acuity (BCVA), and complications over a 6-month follow-up period.
  
  
  RESULTS
  The number of patients with >or=1+ cells in AC and vitreous was significantly lower after treatment than at baseline (each, P<0.01 at the follow-up examinations). The anti-inflammatory effect lasted for the 6-month follow-up period. Laser flare photometry values were also significantly lower than the baseline levels at 3 (P<0.01) and 6 (P=0.034) months. BCVA did not differ before and after treatment. Macular oedema was reduced in 27%, unchanged in another 59%, and worse in 14%. Within 6 months, ocular hypertension was observed in up to 8% and progressing cataract was noted in 29%.ConclusionsOFTA injections improved AC and vitreous inflammation, but the effect on visual acuity and macular oedema was limited.
authors.affiliation: Department of Ophthalmology, St Franziskus Hospital, University Duisburg-Essen, Muenster, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Roesel
authors.forename: M
authors.initials: M
authors.lastname: Gutfleisch
authors.forename: C
authors.initials: C
authors.lastname: Heinz
authors.forename: B
authors.initials: B
authors.lastname: Heimes
authors.forename: B
authors.initials: B
authors.lastname: Zurek-Imhoff
authors.forename: A
authors.initials: A
authors.lastname: Heiligenhaus
mesh_terms: D000328:Adult; D000867:Anterior Chamber / Q000166:cytology / Q000473:pathology; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007267:Injections / Q000379:methods; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010783:Photometry / Q000379:methods; D012189:Retrospective Studies; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014605:Uveitis / Q000188:drug therapy* / Q000473:pathology; D014792:Visual Acuity; D014822:Vitreous Body / Q000166:cytology / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D014222:Triamcinolone Acetonide